CUMYL-CB-MEGACLONE
Designer drug / From Wikipedia, the free encyclopedia
CUMYL-CB-MEGACLONE (CUMYL-CBMGACLONE, SGT-273) is a gamma-carboline based synthetic cannabinoid receptor agonist that has been sold as a designer drug, first being identified in Hungary in April 2020.[1]
Quick Facts Legal status, Identifiers ...
Legal status | |
---|---|
Legal status |
|
Identifiers | |
| |
Chemical and physical data | |
Formula | C25H26N2O |
Molar mass | 370.496 g·mol−1 |
3D model (JSmol) | |
| |
|
Close